BPC-157
Body Protection Compound-157
The most researched healing peptide for joints, tendons, and gut tissue.
Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptides discussed may be research compounds not approved for human use. Always consult a qualified healthcare provider before starting any peptide protocol. Read our full disclaimer →
Quick Reference
| Peptide Class | Pentadecapeptide |
| Half-Life | ~4 hours (injectable) |
| Administration | Subcutaneous injection, Intramuscular injection, Oral (limited absorption) |
| Typical Dosage | 200–500 mcg/day |
| Cycle Length | 4–8 weeks |
| Evidence Level | Strong Preclinical / Limited Human |
| Legal Status | Research compound — not FDA-approved for human use |
| Approximate Cost | $30–$80 per vial |
How BPC-157 Works
Upregulates growth hormone receptors, modulates nitric oxide signaling, and promotes angiogenesis.
BPC-157 exerts its regenerative effects through multiple converging pathways. It upregulates growth hormone receptors in tendon fibroblasts, accelerating the proliferation of cells critical to connective tissue repair. It modulates nitric oxide (NO) signaling — a key mediator of vascular tone and inflammation — which explains its dual role in both healing and anti-inflammatory activity. BPC-157 also promotes angiogenesis (new blood vessel formation), which is essential for delivering nutrients and oxygen to injured tissue. In the gut, it protects the mucosal lining by stimulating the expression of cytoprotective genes and modulating the gut-brain axis through vagal nerve pathways.
Evidence Base
Preclinical Evidence
Rodent studies consistently demonstrate accelerated healing of tendons, ligaments, muscles, and gut tissue. In tendon transection models, BPC-157-treated animals showed significantly faster functional recovery and histological healing compared to controls. Gut protection studies show near-complete prevention of NSAID-induced gastric ulcers and acceleration of inflammatory bowel disease resolution.
Human Evidence
Human clinical data remains limited. One small pilot study in patients with inflammatory bowel disease showed promising mucosal healing results. No large-scale randomized controlled trials have been completed. The compound is not FDA-approved, and all human use is technically off-label research use.
Anecdotal Evidence
BPC-157 has one of the largest anecdotal evidence bases in the research peptide community. Athletes and biohackers consistently report accelerated recovery from tendon injuries (particularly Achilles and rotator cuff), resolution of chronic joint pain, and significant improvement in gut symptoms including IBS and leaky gut. The compound is widely regarded as one of the safest and most reliable research peptides.
Key PubMed References:
Safety Profile
Side Effects
Generally well-tolerated in preclinical studies. Reported side effects in human use are rare and typically mild: nausea (especially at higher doses), dizziness, and injection-site reactions. No serious adverse events have been documented in the literature.
Contraindications
No absolute contraindications established. Caution advised in individuals with active cancer (theoretical angiogenesis concern, though unproven). Not recommended during pregnancy or breastfeeding due to lack of safety data.
PeptidePilot Assessment
BPC-157 is PeptidePilot's top recommendation for users in the Pain & Injury domain who report joint pain, tendon issues, or gut dysfunction. In our algorithm, it scores highest for users who select 'Heal an injury or chronic pain' as their primary goal and report moderate-to-significant joint or gut symptoms. It is also a strong secondary match for athletes with high training loads who experience chronic soreness. The compound's safety profile and breadth of applications make it one of the most versatile entry points into research peptide protocols.
📊 18% of PeptidePilot users with joint or gut concerns receive BPC-157 as their top match
Frequently Asked Questions
Explore More Peptides
Systemic tissue repair and anti-inflammatory recovery for athletes and injury rehabilitation.
The cleanest growth hormone secretagogue for muscle growth, fat loss, and sleep quality.
Extended-release GHRH analogue that amplifies and sustains growth hormone pulses.
The clinically established GHRH analogue with the longest safety record in anti-aging medicine.
The most clinically validated peptide for weight loss and metabolic health.
The next-generation dual-agonist delivering superior weight loss to Semaglutide in clinical trials.